share_log
Reuters ·  May 9 08:08
Inhibikase Therapeutics Inc - FDA Indicated Ikt-001Pro Is Eligible for Exclusivity Designations in Pulmonary Arterial Hypertension
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment